Art
J-GLOBAL ID:200902252807583477   Reference number:04A0113735

Renoprotective Effect of Losartan in Comparison to Amlodipine in Patients with Chronic Kidney Disease and Hypertension-a Report of the Japanese Losartan Therapy Intended for the Global Renal Protection Hypertensive Patients (JLIGHT) Study

慢性腎疾患と高血圧を有する患者におけるアムロジピンとロサルタンの腎保護効果の比較 JLIGHT(Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients)研究の報告
Author (9):
Material:
Volume: 27  Issue:Page: 21-30  Publication year: Jan. 2004 
JST Material Number: Y0303A  ISSN: 0916-9636  Document type: Article
Article type: 原著論文  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0113735&from=J-GLOBAL&jstjournalNo=Y0303A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for cardiovascular system diseases  ,  Drug therapy(=pharmacotherapy)for urogenital diseases  ,  Clinical application of vasoactive drugs and hypotensive drugs 
Substance index (2):
Substance index
Chemical Substance indexed to the Article.
Reference (27):
  • 1. Burnier M, Brunner HR: Comparative antihypertensive effects of angiotensin II receptor antagonists. J Am Soc Nephrol 1999; 10: S278-S282.
  • 2. Aros C, Remuzzi G: The rennin-angiotensin system in progression, remission and regression of chronic nephropathies. J Hypertens 2002; 20 (Suppl 3): S45-S53.
  • 3. Jafar TH, Schmid CH, Landa L, et al: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. Ann Intern Med 2001; 135: 73-87.
  • 4. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-394.
  • 5. Powrie JK, Thomas S: Microalbuminuria: should lowering albumin excretion be a therapeutic goal? Int J Clin Pract 1999; 53: 492-493.
more...

Return to Previous Page